MiNK Therapeutics | 10-K: Annual report
MiNK Therapeutics | 8-K: MiNK Reports Fourth Quarter and Year-End 2023 Results
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behner Peter
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ryan Barbara
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WIINBERG ULF
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Garo H. Armen(9.68%),The Garo H. Armen Grantor Retained Annuity Trust Agreement 2023 #1(1.90%), etc.
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Dijk Marcus Antonius
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Buell Jennifer
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ryan Barbara
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WIINBERG ULF
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behner Peter
MiNK Therapeutics: Q3 2023 Earnings Report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner AGENUS INC
MiNK Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Buell Jennifer
No Data